Treatment-related myelodysplasia following fludarabine combination chemotherapy von Tam, CS, Seymour, JF, Prince, HM, Kenealy, M, Wolf, M, Januszewicz, EH, Westerman, D

Volltext

Cardiovascular toxicity is increased, but manageable, during high-dose chemotherapy and autologous peripheral blood stem cell transplantation for patients aged 60 years and older von Mileshkin, L. R., Seymour, J. F., Wolf, M. M., Gates, P., Januszewicz, E. H., Joyce, P., Prince, H. M.

Volltext

Predictive factors for successful stem cell mobilization in patients with indolent lymphoproliferative disorders previously treated with fludarabine von Morgan, S J, Seymour, J F, Grigg, A, Matthews, J P, Prince, H M, Wolf, M M, Januszewicz, E H

Volltext

Fludarabine and cyclophosphamide using an attenuated dose schedule is a highly effective regimen for patients with indolent lymphoid malignancies von Tam, Constantine S., Wolf, Max M., Januszewicz, E. Henry, Prince, H. Miles, Westerman, David, Seymour, John F.

Volltext

A new model for predicting infectious complications during fludarabine‐based combination chemotherapy among patients with indolent lymphoid malignancies von Tam, Constantine S., Wolf, Max M., Januszewicz, E. Henry, Grigg, Andrew P., Prince, H. Miles, Westerman, David, Seymour, John F.

Volltext

Intrathecal Chemotherapy alone is Inadequate Central Nervous System Prophylaxis in Patients with Intermediate-grade Non-Hodgkin's Lymphoma von Chua, S.L., Seymour, J.F., Streater, J., Wolf, M.M., Januszewicz, E.H., Prince, H.M.

Volltext

A phase II study of liposomal doxorubicin, vincristine and dexamethasone in multiple myeloma von Hönemann, Dirk, Prince, H Miles, Seymour, John F, Wolf, Max M, Westerman, David, Januszewicz, E Henry

Volltext

Hodgkin's disease type Richter's syndrome in chronic lymphocytic leukemia von Juneja, S, Carney, D, Ellis, D, Januszewicz, E H, Wolf, M, Prince, H M

Volltext

Docetaxel effectively mobilizes peripheral blood CD34+ cells von PRINCE, H. M, TONER, G. C, WOLF, M, JANUSZEWICZ, E. H, RICHARDSON, G, SCARLETT, J, BRIGGS, P, BRETTELL, M, RISCHIN, D, SEYMOUR, J. F, BLAKEY, D, GATES, P, EERHARD, S, CHAPPLE, P, WALL, D, QUINN, M, JUNEJA, S

Volltext

Repetitive high-dose therapy with cyclophosphamide, thiotepa and docetaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast c... von PRINCE, H. M, RISCHIN, D, JUNEJA, S, WOLF, M, JANUSZEWICZ, E. H, RICHARDSON, G, SCARLETT, J, BRIGGS, P, TONER, G. C, SEYMOUR, J. F, BLAKEY, D, GATES, P, EERHARD, S, CHAPPLE, P, QUINN, M, BRETTELL, M

Volltext

Repetitive high-dose therapy with ifosfamide, thiotepa and paclitaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer... von Prince, H. M., Millward, M. J., Rischin, D., Blakey, D., Francis, P., Gates, P., Chappie, P., Quinn, M., Juneja, S., Wolf, M., Januszewicz, E. H., Seymour, J. F., Brettell, M., Strickland, A., Zalcberg, J., Richardson, G., Scarlett, J., Briggs, P., Toner, G. C.

Volltext

CliniMACS CD34-selected cells to support multiple cycles of high-dose therapy von Prince, H.M., Wall, D., Rischin, D., Toner, G.C., Seymour, J.F., Blakey, D., Haylock, D., Simmons, P., Wolf, M., Januszewicz, E.H., Westerman, D., Richardson, G., Scarlett, J., Briggs, P.

Volltext

Isolex 300i CD34-selected cells to support multiple cycles of high-dose therapy von Prince, H.M., Bashford, J., Wall, D., Rischin, D., Parker, N., Toner, G.C., Seymour, J.F., Blakey, D., Haylock, D., Simmons, P., Francis, P., Wolf, M., Januszewicz, E.H., Richardson, G., Scarlett, J., Briggs, P.

Volltext

Ifosfamide in combination with paclitaxel or doxorubicin : regimens which effectively mobilize peripheral blood progenitor cells while demonstrating anti-tumor activity in patients... von PRINCE, H. M, GARDYN, J, JANUSZEWICZ, E. H, RICHARDSON, G, SCARLETT, J, BRIGGS, P, BRETTELL, M, TONER, G. C, MILLWARD, M. J, RISCHIN, D, FRANCIS, P, GATES, P, CHAPPLE, P, QUINN, M, JUNEJA, S, WOLF, M

Volltext

High-dose therapy and autologous transplantation for lymphoma: The Peter MacCallum Cancer Institute experience von Dowling, A. J., Prince, H. M., Wirth, A., Wolf, M., Januszewicz, E. H., Juneja, S., Seymour, J. F., Gates, P., Smith, J. G.

Volltext

GM-CSF administration after transplantation of purged autologous marrow [letter; comment] von Januszewicz, EH

Volltext

GM-CSF ADMINISTRATION AFTER TRANSPLANTATION OF PURGED AUTOLOGOUS MARROW von JANUSZEWICZ, E.H.

Volltext

BCR/ABL amplification in chronic myelocytic leukemia blast crisis following imatinib mesylate administration von Campbell, Lynda J., Patsouris, Crisoula, Rayeroux, Kathleen C., Somana, Kathy, Januszewicz, E.Henry, Szer, Jeffrey

Volltext

Fludarabine and high dose cytarabine (FLA): a well tolerated salvage regimen in acute myeloid leukaemia von STRICKLAND, A. H., SEYMOUR, C., PRINCE, H. M., WOLF, M., JUNEJA, S., JANUSZEWICZ, E. H.

Volltext

Correlation of cytogenetics, BCR-ABL PCR studies and fluorescence in situ hybridisation (FISH) in adult acute lymphoblastic leukaemia von Campbell, L. J., Martinow, A., Michael, P. M., White, J. S., Rayeroux, K. C., Januszewicz, E. H.

Volltext